Tylenol Extra Strength Acetaminophen Tablets

Tylenol is one of the world's most recognized brands of pain relief and fever reduction medication, centered on the active ingredient acetaminophen. The brand has a history dating back to the mid-1950s when it was introduced as a safer alternative to aspirin for children. The product shown in the image is the Canadian market version, as indicated by the English and French bilingual labeling and the Drug Identification Number (DIN).

Manufacturing for Tylenol products primarily occurs in the United States, specifically at large-scale facilities such as the Fort Washington plant in Pennsylvania. However, due to its global reach, supply chains can involve production and packaging in multiple countries depending on regional market demand and regulatory requirements.

Originally developed by McNeil Laboratories, the brand became a staple of Johnson & Johnson for decades. In 2023, Johnson & Johnson completed a corporate spin-off of its consumer health division, creating a new independent company called Kenvue. As of 2024 and beyond, Kenvue is the ultimate owner and operator of the Tylenol brand, managing its global distribution and continuous product development.